Globeflex Capital’s Ambit Biosciences Corp AMBI Stock Holding History

Globeflex Capital’s Portfolio AMBI Stock Details AMBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-80	Closed	–	–	754
2013 Q4	$0	Buy	+80	New	+$1.07K	﹤0.01%	733

Other funds holding AMBI

Foresite Capital Management I Larkspur, California $21.4M AUM 80.48% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Globeflex Capital's AMBI Position: Q1 2014 in Review

Globeflex Capital sold out of Ambit Biosciences Corp (AMBI) in Q1 2014, closing a stake of 80 shares.

Globeflex Capital first reported a position in AMBI in Q4 2013 and held it in 1 quarter. The position peaked at $0 in Q4 2013. 46 funds tracked by Wall St. Rank hold AMBI as of Q1 2014.

Globeflex Capital reported no remaining Ambit Biosciences Corp position as of Q1 2014 after selling out during the quarter.
Globeflex Capital sold 80 Ambit Biosciences Corp shares in Q1 2014.
Globeflex Capital first reported a position in Ambit Biosciences Corp in Q4 2013 and held it in 1 quarter.
Globeflex Capital's Ambit Biosciences Corp position peaked at $0 in Q4 2013.
46 funds tracked by Wall St. Rank held Ambit Biosciences Corp as of Q1 2014.

Based on Globeflex Capital's 13F filing for Q1 2014, filed 23 Apr 2014.